ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on dexcom.com/downloadsandguides before purchasing. Consult your healthcare professional to see if this product is right for you.

Stay on track to be your best,
with Dexcom Continuous Glucose Monitoring
Meet Dexcom CGM
Dexcom Continuous Glucose Monitoring (CGM) Systems are a glucose management tool that measures glucose levels 24 hours a day using a sensor inserted just under the skin. It sends glucose numbers to your smartphone* in real time, without fingerpricks†. This allows you to leave the guesswork behind and easily see your glucose levels, how fast they are rising or falling, and to understand how your body reacts to food and physical activity.
* Smart devices sold separately
Find the right Dexcom CGM for you.
Whatever your glucose needs are, we have a real-time CGM for you.

* Smart device sold separately.
Discover our advanced CGM with insulin pump connectivity and predictive alerts.
- For people living with type 1 diabetes
- Insulin pump connectivity
- Up to 9 alert setting options (including Urgent Low Soon)
The Australian Government offers access to subsidised CGM for Australians living with type 1 diabetes through the National Diabetes Services Scheme (NDSS) Initiative.‡

* Smart device sold separately.
Discover our easy CGM with essential alerts for people living with type 2 diabetes.
- For people living with type 2 diabetes
- Insulin pump connectivity not supported
- Up to 5 alert setting options (including Delayed First High)
Visit our online store to view our flexible purchasing options.
Have questions and wish to speak to a Dexcom representative?
Submit the form to connect with our Dexcom representative, receive tips and tricks on Dexcom CGMs, and also be the first to know about upcoming events.
The Dexcom difference
Dexcom CGMs are for people aged 2 years or older living with type 1, type 2 and gestational diabetes where self-monitoring of blood glucose (SMBG) is indicated.

easy to use
- Zero fingerpricks.†
- 30-minute warmup, fastest of any CGM on the market.§
- 10-day sensor wear with an additional 12-hour grace period.
- Waterproof when swimming, showering, and exercising. ||
- Easy and intuitive, all-in-one wearable.

superior accuracy¶,1
- Accurate across all days of wear, glucose levels (2.2 to 22.2 mmol/L) and ages (2+).6-7
- Dexcom CGM is the #1 researched CGM brand in the world.^
* Smart device sold separately.

better health outcomes1-5
- Improve your quality of life8-9
- Improve HbA1c1-5
- Reduce highs and lows1-5
- Increase time in range1-5

Dexcom Follow app** for friends and family
The Dexcom share feature allows friends, loved ones or caretakers to follow your glucose levels, giving you a circle of support.
Clarity integration
Allows you to automatically share CGM data with your healthcare professional and see simple insights.

Dexcom G7's advanced features

Dexcom G7 has a refined suite of alert settings, including Urgent Low Soon alert and the new Silence All or Vibrate modes for added discretion and personalisation. The Urgent Low Soon alert provides a 20-minute advance warning of when you’ll reach 3.1 mmol/L so that you can act quickly and avoid a potential hypoglycemic event.

Dexcom G7 is the world's largest connected CGM††, making it seamless to connect to various smart devices,* health apps, and insulin delivery devices, including insulin pumps.
Dexcom ONE+ and Dexcom G7 components

All-in-one sensor
Measures glucose levels for up to 10 days, with a 12-hour grace period. The 24.1 mm height makes it our smallest sensor.

One-push applicator
Inserts the sensor. Its clever design means you only have to push the button to get started.

Dexcom G7 / Dexcom ONE+ app
Dexcom G7 or Dexcom ONE+ app displays readings in real-time on your smartphone.*
The Dexcom share feature allows friends, loved ones or caretakers to follow your glucose levels, giving you a circle of support.
* Smart devices sold separately.

Optional receiver‡‡
Displays readings in real-time. The 11.9 mm slim design makes itself ideal for people without a compatible smartphone.
Looking for technical assistance?
Speak to one our our technical support team members today.
Dexcom G7 and Dexcom ONE+ are continuous glucose monitoring systems indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated. The web-based Dexcom Clarity software is intended for use by both home users and healthcare professionals to assist people living with diabetes and their healthcare professionals in the review, analysis, and evaluation of historical CGM data to support effective glucose management. It is intended for use as an accessory to Dexcom CGM devices with data interface capabilities.
† If your glucose alerts and readings from Dexcom CGM do not match symptoms or expectations, use a blood glucose meter to make glucose treatment decisions. *Smart device sold separately. For a list of compatible devices, visit www.dexcom.com/compatibility. ‡ Eligibility criteria applies. Visit ndss.com.au/cgm for more details. § Dexcom G7 and Dexcom ONE+ can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer. || The Dexcom G7 and Dexcom ONE+ sensor’s are waterproof and may be submerged under 2.4 metres of water for up to 24 hours without failure when properly installed. ¶ As compared to Dexcom G6 System. # Compared to previous generations of Dexcom systems. ^ Based on comparison of completed trials registered at clinicaltrials.gov as of March 2025. ** Separate Follow app and internet connection required. †† Not all connections are available in Australia. To learn more about insulin pump integrations and compatibility with Dexcom CGM Systems, visit dexcom.com/compatibility. ‡‡ A touchscreen receiver can be acquired as an optional display device.
1. Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7. 2. Beck RW, et al. JAMA. 2017;317(4):371-378. 3. Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 4. Martens T, et al. JAMA. 2021;325(22):2262-2272. 5. Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 6. Garg SK, et al. Diabetes Technol Ther. 2022;24(6):373-80. 7. Laffel LM, et al. J Diabetes Sci Technol. 2023;17(4):962-7. 8. Polonsky WH, et al. Diabetes Technol Ther. 2021;23(3):195-202. 9. Gilbert TR, et al. Diabetes Technol Ther. 2021;23(S1):S35-S39.
Dexcom, Dexcom G7, Dexcom G6, Dexcom ONE+, Dexcom Clarity, Dexcom Follow and Dexcom Share are registered trademarks of Dexcom, Inc. in the United States and/or other countries.
MAT-8664